Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshimi Sakamoto

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Radiation Research|January 3, 2024
Enhanced induction of abnormal telomere FISH signals in response to oxidative DNA damageYoshimi Sakamoto, Kazunori Shiraishi, Seiji Kodama
Biochemical and Biophysical Research Communications|August 24, 2020
Comparison of the ischemic and non-ischemic lung cancer metabolome reveals hyper activity of the TCA cycle and autophagyNaohiko Kikuchi, Tomoyoshi Soga, Miyuki Nomura, et al.
Bioorganic & Medicinal Chemistry|May 12, 2012
Cleavage mechanism and anti-tumor activity of 3,6-epidioxy-1,10-bisaboladiene isolated from edible wild plantsKen-ichi Kimura, Yoshimi Sakamoto, Nozomi Fujisawa, et al.
FEBS Letters|January 18, 2020
Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancerKei Kudo, Miyuki Nomura, Yoshimi Sakamoto, et al.
International Journal of Molecular Sciences|December 17, 2024
Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous MelanomaGabriel Alves Freiria de Oliveira, Daniel Arcuschin de Oliveira, Melissa Yoshimi Sakamoto Maeda Nisimoto, et al.
Oncology Research|June 1, 2026
EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic PerspectivesDaniel Arcuschin de Oliveira, Melissa Yoshimi Sakamoto Maeda Nisimoto, Jaciara Moreira Sodré Hunnicutt, et al.
Oncology Letters|January 19, 2018
<i>Ex vivo</i> model of non-small cell lung cancer using mouse lung epithelial cellsTaku Sato, Mami Morita, Ryota Tanaka, et al.
Molecules (Basel, Switzerland)|August 14, 2020
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase InhibitorsSei-Ichi Tanuma, Kiyotaka Katsuragi, Takahiro Oyama, et al.
Cancer Medicine|June 19, 2021
Ppp6c deficiency accelerates K-ras<sup>G12D</sup> -induced tongue carcinogenesisKazuhiro Kishimoto, Kosuke Kanazawa, Miyuki Nomura, et al.
Nature Communications|December 13, 2023
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinomaMiyuki Nomura, Mai Ohuchi, Yoshimi Sakamoto, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Radiation Research|January 3, 2024
Enhanced induction of abnormal telomere FISH signals in response to oxidative DNA damageYoshimi Sakamoto, Kazunori Shiraishi, Seiji Kodama
Biochemical and Biophysical Research Communications|August 24, 2020
Comparison of the ischemic and non-ischemic lung cancer metabolome reveals hyper activity of the TCA cycle and autophagyNaohiko Kikuchi, Tomoyoshi Soga, Miyuki Nomura, et al.
Bioorganic & Medicinal Chemistry|May 12, 2012
Cleavage mechanism and anti-tumor activity of 3,6-epidioxy-1,10-bisaboladiene isolated from edible wild plantsKen-ichi Kimura, Yoshimi Sakamoto, Nozomi Fujisawa, et al.
FEBS Letters|January 18, 2020
Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancerKei Kudo, Miyuki Nomura, Yoshimi Sakamoto, et al.
International Journal of Molecular Sciences|December 17, 2024
Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous MelanomaGabriel Alves Freiria de Oliveira, Daniel Arcuschin de Oliveira, Melissa Yoshimi Sakamoto Maeda Nisimoto, et al.
Oncology Research|June 1, 2026
EZH2 in Acral Lentiginous Melanoma: Molecular, Epigenetic, and Therapeutic PerspectivesDaniel Arcuschin de Oliveira, Melissa Yoshimi Sakamoto Maeda Nisimoto, Jaciara Moreira Sodré Hunnicutt, et al.
Oncology Letters|January 19, 2018
<i>Ex vivo</i> model of non-small cell lung cancer using mouse lung epithelial cellsTaku Sato, Mami Morita, Ryota Tanaka, et al.
Molecules (Basel, Switzerland)|August 14, 2020
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase InhibitorsSei-Ichi Tanuma, Kiyotaka Katsuragi, Takahiro Oyama, et al.
Cancer Medicine|June 19, 2021
Ppp6c deficiency accelerates K-ras<sup>G12D</sup> -induced tongue carcinogenesisKazuhiro Kishimoto, Kosuke Kanazawa, Miyuki Nomura, et al.
Nature Communications|December 13, 2023
Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinomaMiyuki Nomura, Mai Ohuchi, Yoshimi Sakamoto, et al.
Pageof 2